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Abstract
Brown adipose tissue in mammals plays a critical role in maintaining energy balance by thermogenesis, which
means dissipating energy in the form of heat. It is held that in mammals, long-term surplus food intake results in
energy storage in the form of triglyceride and may eventually lead to obesity. Stimulating energy-dissipating
function of brown adipose tissue in human body may counteract fat accumulation. In order to utilize brown
adipose tissue as a therapeutic target, the mechanisms underlying brown adipocyte differentiation and function
should be better elucidated. Here we review the molecular mechanisms involved in brown adipose tissue
development and thermogenesis, and share our thoughts on current challenges and possible future therapeutic
approaches.
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Introduction of brown adipose tissue and
thermogenesis
Adipose depots in different parts of the body have unique
micromorphology and molecular markers. According to
their distinct physiological roles, adipose tissue in mam-
mals is categorized into white adipose tissue (WAT) and
brown adipose tissue (BAT) [1]. WAT functions to store
energy in the form of triglyceride (TG)-containing intra-
cellular droplets as well as to secrete a host of hormones
that regulate overall energy balance. Unlike WAT, BAT
regulates thermogenesis upon environmental stresses to
maintain energy balance and protect the organism from
hypothermia [2]. In addition, it has been shown that by
activating BAT via short-term cold exposure, fatty acids
are efficiently channeled into BAT due to a metabolic pro-
gram that boosts TG-rich lipoproteins (TRL) uptake into
BAT. In consequence, lipids clearance from plasma
becomes more efficient, implicating that BAT might be a
master regulator of TRL clearance and blood lipid abun-
dance [3].
BAT thermogenesis is achieved by dissipating heat pro-
duced from fatty acid oxidation. As little as 50 g of BAT
could account for up to 20% of basal metabolic energy
expenditure of an adult human when maximally stimu-
lated [4]. When animals are subjected to cold environment
or ingest surplus energy, their sympathetic nervous system
will be stimulated and catecholamine will be released.
Catecholamine binds to the b3-Adrenoceptor on the
plasma membrane of brown adipocyte and activates ade-
nylyl cyclase which is able to accelerate the conversion of
ATP to cyclic AMP (cAMP) [5]. cAMP is able to activate
type 2 deiodinase (Dio2), an enzyme that converts thyroid
h o r m o n eT 4t oT 3i nt h eb r o w na d i p o c y t e ,r e s u l t i n gi n
enhanced local thyroid hormone signaling and increased
energy. In addition, cAMP activates protein kinase A,
which, in turn, phosphorylates and activates triacylglycerol
lipase. Then the lipase accelerates the release of free fatty
acid from triacylglycerol contained in the droplet of brown
adipocyte, which acts both as the fuel of thermogenesis
and as an activator of uncoupling protein 1 (UCP1), a key
component of thermogenesis. UCP1 activation results in
fast substrate oxidation with a low rate of ATP production.
Thus, a large amount of energy is dissipated in the form of
heat, which will be distributed throughout the body by cir-
culation system [1,6].
Overview of recent breakthroughs in the study
of BAT
It was previously believed that brown adipocyte and
white adipocyte share a common ancestor in the course
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rendered in 2007 when PR domain containing 16
(PRDM16) was discovered to be a master regulator of
brown adipocyte differentiation [6]. Investigation of its
specific role in brown adipocyte commitment led to the
discovery that skeletal muscle and some depots of BAT
s h a r eac o m m o nm y o g e n i cf a c t o r5( M y f 5 ) - e x p r e s s i n g
progenitor [7]. Besides classic interscapular brown adi-
pocytes, brown-like adipocytes (brite adipocytes) were
found in WAT depots. When rats were submitted to
cold or treated with b-adrenoceptor agonist, UCP1
could be detected in fat pads which had been considered
as WAT. UCP1 was expressed in cells morphologically
identical to typical brown adipocytes found in interscap-
ular BAT [8]. More recent data suggested that there
were inducible brown adipocytes in WAT when mice
were exposed to cold environment [9]. These inducible
brown adipocytes were not derived from Myf5-expres-
sing myoblasts, and had a distinct gene expression pro-
file in comparison with those adipocytes in interscapular
BAT.
The mesenchymal stem cell is the precursor of brown
adipocytes. BAT formation occurs in the early phase of
embryonic development [10]. Once it was suggested that
only small mammals and new born infants possess BAT,
while human adults are practically devoid of functional
BAT [1]. However, several research papers published in
New England Journal of Medicine in 2009 rebutted this
assumption [11-14]. After analyzing thousands positron
emission computed tomography/computed tomography
(PET/CT) scans of adult subjects, researchers found that
BAT was located in the neck and upper-chest regions.
Moreover, BAT ratio was conversely correlated with body
mass index (BMI) and this correlation was more signifi-
cant among elderly [12]. Development of obesity is a result
of prolonged positive energy balance. Most of surplus
energy is stored in adipose tissue. Since BAT is essential in
maintaining the balance of body fat and keeping indivi-
duals from obesity, now BAT has been considered a pro-
mising therapeutic target to combat obesity. We need to
further delineate the mechanisms involved in brown adi-
pose differentiation and thermogenesis, although they
have been studied extensively (Figure 1).
Key players involved in brown adipose
thermogenesis and differentiation
UCP1
As for human, UCP1 genetic polymorphisms were
reported to be correlated with fat metabolism, obesity and
diabetes [15-17]. These genetic studies underlie the role of
UCP1 in maintaining energy balance. UCP1 is predomi-
nantly expressed in brown adipocytes and responsible for
the respiratory uncoupling during BAT thermogenesis [1].
Located on the inner membrane of mitochondria, UCP1
activity is regulated at multiple levels. There exist peroxi-
some proliferator responsive element (PPRE) [18], thyroid
hormone responsive element (TRE) [19], and retinoic acid
responsive element (RARE) [20] in the upstream of UCP1
gene, which means these nuclear receptors and their
ligands might directly regulate its transcription. In addi-
tion, peroxisome proliferator-activated receptor gamma
coactivator 1-alpha (PGC-1a), which is critical to mito-
chondria genesis, is able to increase the transcriptional
activity of peroxisome proliferator-activated receptor g
(PPARg) and thyroid hormone receptor (TR) on the UCP-
1 promoter [21]. UCP1 activity can also be directly regu-
lated by purine nucleotides and free fatty acids. Purine
nucleotides bind from the cytosolic side of UCP1 and inhi-
bit its activity [22]. Free fatty acids released in response to
stimuli can replace the purine nucleotides and act as a
UCP1 activator [23,24]. After the residual fatty acids are
oxidized away, the mitochondria will return to coupled
state.
Thyroid hormone and Dio2
Thyroid hormone is necessary for a full BAT thermo-
genic response in cold adaptation. In the hypothyroid
state, the response of BAT to sympathetic stimulation is
diminished [25]. Mice deficient in TRa are cold intoler-
ant and have impaired BAT thermogenic response to
norepinephrine [26]. In addition, activation of thyroid
hormone signaling is highly regulated by deiodination.
Deiodination of minimally active thyroxine (T4) to the
biologically active triiodothyronine (T3) is catalyzed by
type I and type II deiodinases (Dio1 and Dio2) [27]. Dio2
expression has been shown to control intracellular T3
concentration. In response to sympathetic stimulation,
increased cAMP stimulates T3 production by increasing
Dio2 expression and activity, which leads to increased
energy expenditure in BAT. Mice lacking Dio2 exhibit
permanent BAT thermogenic defect, compromising ther-
moregulation and the ability to dissipate excessive cal-
ories from diet [28-30]. Interestingly, bile acids released
from the gallbladder has been shown to increase energy
expenditure in BAT by regulating local thyroid hormone
production via G protein-coupled receptor TGR5-cAMP-
Dio2 signaling pathway [31,32].
PGC-1a
Before the identification of PRDM16 in brown adipocytes,
PGC-1a was considered as a major regulator in brown
adipocyte function. PPARg is a nuclear receptor critical for
both WAT and BAT formation, which was evidenced by
the substantial studies in knockout mice [33]. PGC-1a,
discovered as a coactivator for PPARg,i sb e l i e v e dt od e t e r -
m i n et h es p e c i f i cr o l eo fP P A R g to promote UCP1 tran-
s c r i p t i o ni nb r o w na d i p o c y t e s[ 2 1 ] .P G C - 1 a content is
higher in BAT than in WAT. PGC-1a expression
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[34]. Moreover, PGC-1a can induce the expression of
nuclear respiratory factor (NRF) and physically interact
with NRF to coactivate the transcription. NRF is able to
regulate a host of mitochondrial genes encoded in the cell
nucleus, including b-ATP synthase, cytochrome-c, cyto-
chrome-c-oxidase subunit IV, and mitochondrial tran-
scription factor A [35]. Cold exposure significantly
stimulates PGC-1a expression, which is mediated by pro-
tein kinase A-cAMP response element-binding protein
(PKA-CREB) pathway [21]. Ectopic expression of PGC-1a
in WAT leads to mitochondria genesis and UCP1 upregu-
lation. Lack of PGC-1a in mice does not affect the
morphology of BAT but results in lower UCP1 level and
intolerance to cold [36,37]. Correspondingly, loss of PGC-
1a in cultured brown preadipocytes does not impede the
maturation, but the matured adipocytes have impaired
thermogenesis [34]. Thus, it can be concluded that PGC-
1a is an important part of thermogenesis due to its indis-
pensable role in mitochondria genesis while it has limited
effect on brown adipocyte differentiation.
RIP140
Receptor-interacting protein 140 (RIP140), a nuclear
receptor corepressor, can suppress nuclear receptor
estrogen receptor (ER) and PPAR in the presence of their
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Figure 1 Schematic representation of the effect of key regulators involved in brown adipose differentiation.
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than in BAT [39,40]. It was reported that RIP140 defi-
ciency in cultured adipocytes led to increased energy
expenditure and this phenomenon disappeared if RIP140
was re-expressed [41]. In vivo studies show that RIP140
-/-
mice consume a similar amount of food as control mice,
while their physical activity remains unaltered. The mice
appear to be emaciated with a total fat tissue content
dropped to 30% of that in control mice. However, in
these mice, the fat cell number remains the same com-
pared to the control group, but the volume decreases sig-
nificantly. Moreover, the RIP140
-/- mice are protected
from high-fat diet-induced obesity. It is of particular
interest that UCP1 expression in the WAT of these mice
is 100 times higher than that in the WAT of wild type
mice [39]. This finding suggests that RIP140 might be
able to suppress brown adipocyte characteristics.
PRDM16
PRDM16, a 140-kDa protein, contains an N-terminal PR
domain, ten zinc-fingers and other diverse sites that can
mediate multiple protein-protein interaction. PRDM16
plays a critical role in determining brown adipocyte line-
age commitment and differentiation. By comparing the
transcriptome of BAT and WAT from mice, PRDM16 was
for the first time recognized as a BAT-specific gene [6].
When PRDM16 is expressed in white fat cell progenitors,
it can activate a robust brown fat phenotype including
induction of PGC-1a, UCP1, and Dio2 expression and a
remarkable increase in uncoupled respiration. Transgenic
expression of PRDM16 in white fat depots stimulates the
formation of brown fat cells. In contrast, knockdown of
PRDM16 through shRNA expression in brown fat cells
causes a near total loss of the brown characteristics. It is
suggested that PRDM16 activates brown fat cell identity at
least in part by simultaneously activating PGC-1a and
PGC-1b through direct binding [6], and represses white
adipocyte gene expression through forming complex with
C-terminal-binding protein-1 (CtBP-1) and CtBP-2 [42].
A major breakthrough was achieved by a lineage tracing
study in vivo which has revealed that brown adipocyte
shares a mutual precursor, Myf5-expressing cell, with ske-
letal muscle cell, but not white adipocyte as previously
considered. Loss of PRDM16 from brown adipocyte pre-
cursor promotes muscle differentiation, while ectopic
expression of PRDM16 in myoblasts induces their differ-
entiation into brown adipocytes [7]. Subsequent investiga-
tion indicates that PRDM16 is able to form complex with
CCAAT-enhancer-binding proteinb (C/EBPb)a n dt h i s
complex controls the cell fate switch from myoblastic pre-
cursors to brown fat cells [43]. Forced expression of
PRDM16 and C/EBP-b is sufficient to induce a fully func-
tional brown fat program in naive fibroblastic cells. All the
evidence above demonstrates that PRDM16 plays a critical
role in determining the differentiation fate of brown adi-
pocyte. However, the specific upstream regulator of
PRDM16 remains to be elucidated.
Recently, PRDM16 was also proved to be important in
determining the thermogenic program of subcutaneous
WAT [44]. Transgenic expression of PRDM16 in fat tissue
robustly induces the development of brown-like adipo-
cytes in subcutaneous, but not epididymal, adipose depots.
PRDM16 transgenic mice display increased energy expen-
diture. These findings indicate that PRDM16 is a key regu-
lator for brown fat-like gene program and thermogenesis
in subcutaneous adipose tissues.
Wnt
The Wnt proteins are a group of autocrine or paracrine
secreted glycoproteins [45]. Over ten members have been
uncovered in the Wnt family, all of which participate in
the regulation of embryonic development and mainte-
nance of adult tissue homeostasis. BAT expresses Wnt10a
and Wnt10b. Wnt proteins are found to be downregulated
i nt h ec o u r s eo fb r o w na d i p o cyte formation, suggesting
that these Wnt proteins inhibit the maturation of brown
adipocytes [46]. To investigate the mechanism underlying
the effect of Wnt10b in adipocyte formation in vivo,
Longo et al. constructed transgenic mice which express
Wnt10b specifically in adipose tissue, named as FABP4-
Wnt10b mice [47]. Their investigation discovered that the
BAT development in FABP4-Wnt10b mice is impaired
and the appearance of interscapular BAT resembles that
of WAT. Moreover, the BAT function is deficient, which
is manifested by the fact that the transgenic mice are not
able to maintain core body temperature when exposed to
cold environment [46,47]. In vitro study reported by Kang
et al. shows that PPARg and C/EBPa are involved in the
inhibition of brown adipocyte differentiation caused by
Wnt10b, while the suppression of UCP1 expression is
related to PGC-1a [46]. To specifically express Wnt10b in
BAT, they constructed transgenic mice in which Wnt10b
transcription is under the control of UCP1 promoter
(UCP1-Wnt10b mice). By investigating the histological
morphology of the interscapular BAT, they found that
each adipocyte contains single lipid droplet, which should
have existed only in white adipocytes. In comparison with
BAT of control mice, protein levels of UCP1 and PGC-1a
in UCP1-Wnt10b mice decrease greatly with the suppres-
sion of mitochondria genesis and metabolism, yet the
expression of PPARg and C/EBPa remains unaltered. As a
result, they concluded that in mature brown adipocytes,
enhanced Wnt signaling pathway endows brown adipo-
cytes with significant characters of white adipocytes.
Moreover, reciprocal expression of Wnt10b with UCP1
and PGC-1a in interscapular BAT from cold-challenged
or genetically obese mice provides further evidence for
regulation of brown adipocyte metabolism by Wnt
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Wnt signaling pathway inhibits maturation of brown prea-
dipocyte and suppresses the characters of mature brown
adipocytes.
Pocket protein
Pocket proteins play key roles in cell cycle progression
[48,49]. They can bind to E2F family and inhibit the tran-
scription of target genes [50]. Pocket proteins include reti-
noblastoma protein (pRb), p107 and p130. pRb has been
shown to influence adipocyte differentiation. When
embryonic stem cells of wild type and Rb
-/- mice are
induced to differentiate into adipocytes, UCP1 will be
exclusively expressed in Rb
-/- adipocytes. In addition, Rb
-/-
adipocytes have higher expression level of PGC-1a.
Mouse embryonic fibroblast (MEF) is widely used to study
the process of adipocyte differentiation in vitro.W h e n
MEFs are induced to differentiate into adipocytes, UCP1 is
elevated only in Rb
-/- MEF but not in wild type MEF, and
the PGC-1a level is much higher in the former one. In the
mature adipocytes, the expression level of UCP1 and
PGC-1a is comparable to that of wild type BAT. Observa-
tion of the electron microscopic samples revealed that
pRb-deficient adipocytes have more mitochondria than
the control group [51]. In addition, Rb
-/- adipocytes have
higher levels of forkhead box protein C 2 (Foxc2) and reg-
ulatory type I alpha (RIa) during differentiation as com-
pared to the wild type. Further studies revealed that Foxc2
is indispensable to RIa activation, whereas the activated
RIa is able to enhance cAMP sensitivity because RIa has
very high affinity to cAMP. Enhanced cAMP sensitivity is
critical in the early phase of adipocyte differentiation for
the reason that it can activate CREB and induce the
expression of PGC-1a, thus increases UCP1 expression
level and mitochondria genesis. Alteration of p107,
another member of the pocket proteins, can also affect the
differentiation of adipocytes. As reported by Scime et al. in
2005, WAT of p107
-/- mice are totally replaced by BAT
[52]. Each adipocyte in WAT contains multilocular lipid
droplets with PGC-1a and UCP1 expression levels similar
to that in BAT. Additionally, pRb level decreases in WAT
of p107
-/- mice. To be noted, pRb is able to suppress the
transcription of PGC-1a by binding to its promoter.
Along this line of evidence, it can be concluded that PGC-
1a is the target of p107 and pRb in preadipocytes.
Prostaglandins
Prostaglandins are important biological mediators
derived from fatty acids. They are composed of twenty
carbon molecules, five of which make up a five-member
ring. Cyclooxygenase (COX) is the enzyme catalyzing the
committed step in prostaglandin synthesis. At present,
two COX isoenzymes, COX-1 and COX-2, have been
well studied. They act in a similar fashion in the catalytic
reaction [53]. COX-1 is considered as a constitutive
enzyme, being found in most mammalian cells. COX-2,
on the other hand, is only detectable in specific tissues
when inflammation happens. Being an inducible enzyme,
COX-2 becomes abundant in activated macrophages and
other cells at sites of inflammation [54,55]. Besides being
critical mediators in inflammation, prostaglandins and
C O Xa r ea l s of o u n dt op l a yar o l ei nm a i n t a i n i n ge n e r g y
balance. Mice heterozygous for COX-2 tend to be obese.
Of great interest is the result reported by Vegiogoulos A
et al. in 2010 that COX-2 is one of the targets of adrena-
line stimulation in subcutaneous WAT and critical to the
induction of brown adipocytes in WAT [9]. Treatment of
prostaglandin, the product of COX-2 catalyzed reaction,
is able to promote committed mesenchymal stem cells to
differentiate into adipocytes with brown fat character.
Moreover, overexpression of COX-2 in WAT of mice
effectively induces de novo recruitment of brown adipo-
cytes, elevates the energy expenditure of mice and pro-
tects the mice from high fat diet induced obesity. Before
long, this conclusion was confirmed by Madsen A et al
[56]. These data strongly indicate that COX-2 is critical
for the UCP1 expression in brown adipocytes recruited
in WAT.
BAT and Obesity Treatment
O b e s i t yi sd e f i n e dn o to n l ya sa ne x c e s so fb o d yw e i g h t ,
but also an increased adipose tissue accretion to the extent
that health may be adversely affected. The anti-obesity
medication phentermine and orlistat approved by Food
and Drug Administration (FDA) are designed to suppress
appetite and reduce fat absorption, respectively [57].
Unfortunately, phentermine has adverse effects including
i n c r e a s e dh e a r tr a t ea n de l e v a t e db l o o dp r e s s u r e ,w h i l e
orlistat may cause steatorrhea, fecal incontinence and fre-
quent or urgent bowel movements. Due to the presence of
B A Ti na d u l th u m a n s ,i ti sc o n c e i v a b l et h a tw e i g h tl o s s
can be achieved by increasing energy expenditure through
activating BAT. Until now, two therapeutic strategies have
been suggested in obesity control as shown in Figure 2
[58,59]. One is to stimulate the original BAT development
and function by small molecules. The other is to trans-
plant functional brown adipocytes induced from proper
stem cells into obese patients. The second strategy can be
also considered as BAT transplantation.
Dinitrophenol (DNP) was developed to uncouple the
biological process of oxidative phosphorylation in mito-
chondria and make mitochondria produce heat instead of
ATP [60]. It increases energy expenditure in a sustainable
manner and no drug tolerance would happen. Although
DNP has been withdraw from the market due to the side
effects, including a sensation of warmth, frequently with
sweating and hyperthermia, chemical modification will
hopefully help us develop a better drug [61]. A theory
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set point of body weight. Owning to the concurring effort
of nerve and endocrine system, body weight will fluctuate
in a narrow window. In other words, normal body weight
can be regained even if short term energy intake (or
expenditure) that leads to increased (or decreased)
weight. However, under long term one-way stimulation,
this “set point” can be resettled. This provides a possible
therapy for the obese by treating them with BAT activat-
ing drugs so as to lower their set point.
BAT transplantation becomes increasingly appealing
due to the gradually perfection of stem cell technology.
Adipose tissue transplantation has primarily been used
for human reconstructive surgery. Now, transplantation
of adipose tissue is being explored as a possible tool to
promote the beneficial metabolic effects of subcutaneous
WAT and BAT, as well as adipose-derived stem cells
[62]. Brown adipocytes at varied differentiation stages or
the complete BAT can be transplanted. Cells that can be
transplanted include stromal vascular fraction (SVF), pre-
adipocytes and brown adipocytes. Furthermore, confluent
preadipocytes cultured in dishes, dedifferentiated primary
adipocytes and SVF show better viability than the fully
differentiated adipocytes and mature adipocytes. It is
worth mentioning that the success rate of transplantation
is partially determined by the degree of vascularization
[63].
Problems and Perspectives
Rediscovery of BAT in human adults brought about the
revival of BAT research as an anti-obesity therapy. Despite
the growing number of research results reported, there are
many unanswered questions on BAT development and
thermogenesis, which may be better understood with
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Figure 2 Schematic representation of two BAT-based therapeutic strategies in obesity control.
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recombinase under the control of UCP1 promoter have
not yet been widely applied in the research of BAT. In
addition, negligence of the temperature under which mice
are raised may also mislead the data analysis. 30°C is the
thermoneutral temperature for mice, at which mice main-
tain their body temperature without adaptive nonshivering
thermogenesis. However, mice are usually bred at 22°C, a
temperature that UCP1 can be activated during BAT ther-
mogenesis. As a result, behaviors exhibited by knockout
mice under this circumstance may not solely reflect the
gene function. In addition to environmental temperature,
individual variance of hair density and physical activity,
which influence body temperature and energy expendi-
ture, will also incur error when explaining the phenotypes
observed from mice.
Currently, most efforts are spent to delineate signaling
pathways and transcriptional regulation. Emerging areas
like RNA editing, alternative splicing, non-coding RNA
and epigenetic modification are largely unexplored. During
the preparation of this review, miR-193b-365, a brown-fat-
enriched miRNA cluster, was identified as a key regulator
of brown fat development [63]. Since the BAT develop-
ment and function are highly orchestrated and complex
processes, regulatory mechanisms involved deserve more
attention.
Conclusions
With the help of modern technology, multiple studies con-
clusively show that functional BAT exists in adult humans,
and is inversely correlated with BMI, adipose tissue mass,
glucose and insulin levels. Recently, studies were focused
on illustrating which factors determine the unique feature
of BAT. As summarized above, a great number of mole-
cules are involved in the regulation of brown adipocyte
differentiation and thermogenesis, be it in direct or indir-
ect ways. Animal studies contribute a great deal for us to
understand BAT development and function. However, a
full understanding of BAT biology in humans will only be
completed with clinical evidence. Taking advantage of the
advancement of biomedical technology, we are expecting
the next leap on BAT research.
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